IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
Source: Financial Post· Business Wire· August 11, 2026
SynaBot summary
IDEXX Laboratories has introduced a new point-of-care diagnostic test for detecting cardiac disease in both cats and dogs. This quantitative NT-proBNP test aims to integrate seamlessly into veterinary practice workflows, offering faster results for pet owners.
Key takeaways
- New dual-species cardiac test for cats and dogs launched
- Quantitative NT-proBNP assessment available at point-of-care
- Aims to integrate into veterinary clinic workflows
- Provides faster diagnostic information for pet health
Why it matters
For AI users in veterinary medicine, this means potentially faster and more accessible cardiac diagnostics for pets. This could lead to quicker treatment decisions and improved patient outcomes, streamlining the diagnostic process within clinics.
This story was reported by Financial Post. Read the full original article:
Read on Financial Post Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
AI Tools
- KNIME Analytics PlatformKNIME Analytics Platform is an open-source platform for data science. It enables visual creation of data pipelines and machine learning workflows. Connect to diverse data sources and integrate various data tools.
- Drift Conversational PlatformDrift combines conversational AI with live chat to enhance sales and customer support. Its chatbots engage visitors, answer questions, and route inquiries, optimizing the buyer experience.
- Kore.ai Experience PlatformKore.ai offers an enterprise-grade platform for building highly intelligent virtual assistants and process automation solutions. It supports conversational AI across multiple channels and languages. The platform focuses on delivering transformative customer and employee experiences.
